Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1

Overview

Journal Haematologica

Specialty Hematology

Date 2010 May 6

PMID 20442440

Citations 24

Authors

Barbara J Bain

Affiliations

Soon will be listed here.

Citing Articles

PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.

Katerndahl C, Rogers O, Day R, Xu Z, Helton N, Ramakrishnan S Proc Natl Acad Sci U S A. 2024; 121(18):e2317690121.

PMID: 38648485 PMC: 11067031. DOI: 10.1073/pnas.2317690121.

Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).

Aljabry M J Hematop. 2024; 16(1):27-31.

PMID: 38175368 DOI: 10.1007/s12308-022-00528-1.

Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review.

Marrero R, Lamba J Cancers (Basel). 2023; 15(14).

PMID: 37509244 PMC: 10377605. DOI: 10.3390/cancers15143583.

Systemic Lymphadenopathic Mastocytosis with Eosinophilia.

Im S, Kim J, Park G, Cho U Diagnostics (Basel). 2022; 12(12).

PMID: 36553063 PMC: 9776443. DOI: 10.3390/diagnostics12123057.

Pruritus as a Presenting Symptom of -Positive Chronic Eosinophilic Leukemia.

Abu-Tineh M, Aljaloudi E, Yassin M J Blood Med. 2022; 12:1061-1063.

PMID: 35002348 PMC: 8721926. DOI: 10.2147/JBM.S319441.

References

Sorour Y, Dalley C, Snowden J, Cross N, Reilly J . Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene. Br J Haematol. 2009; 146(2):225-7. DOI: 10.1111/j.1365-2141.2009.07746.x. View

Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C . Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia. 2007; 21(6):1183-8. DOI: 10.1038/sj.leu.2404662. View

Elling C, Erben P, Walz C, Frickenhaus M, Schemionek M, Stehling M . Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease. Blood. 2011; 117(10):2935-43. DOI: 10.1182/blood-2010-05-286757. View

Tashiro H, Shirasaki R, Noguchi M, Gotoh M, Kawasugi K, Shirafuji N . Molecular analysis of chronic eosinophilic leukemia with t(4;10) showing good response to imatinib mesylate. Int J Hematol. 2006; 83(5):433-8. DOI: 10.1532/IJH97.05180. View

Michaux L, Mecucci C, Pereira Velloso E, Dierlamm J, Criel A, Louwagie A . About the t(8;13)(p11;q12) clinico-pathologic entity. Blood. 1996; 87(4):1658-9. View

Chase A, Grand F, Cross N . Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood. 2007; 110(10):3729-34. DOI: 10.1182/blood-2007-02-074286. View

Salemi S, Yousefi S, Simon D, Schmid I, Moretti L, Scapozza L . A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome. Allergy. 2009; 64(6):913-8. DOI: 10.1111/j.1398-9995.2009.01943.x. View

Hidalgo-Curtis C, Apperley J, Stark A, Stark A, Jeng M, Gotlib J . Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms. Br J Haematol. 2010; 148(2):268-73. DOI: 10.1111/j.1365-2141.2009.07955.x. View

Hidalgo-Curtis C, Chase A, Drachenberg M, Roberts M, Finkelstein J, Mould S . The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer. 2008; 47(5):379-85. DOI: 10.1002/gcc.20541. View

10.

Soler G, Nusbaum S, Varet B, Macintyre E, Vekemans M, Romana S . LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome. Leukemia. 2009; 23(7):1359-61. DOI: 10.1038/leu.2009.79. View

11.

Lierman E, Michaux L, Beullens E, Pierre P, Marynen P, Cools J . FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib. Leukemia. 2009; 23(5):845-51. DOI: 10.1038/leu.2009.2. View

12.

Erben P, Gosenca D, Muller M, Reinhard J, Score J, Del Valle F . Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica. 2010; 95(5):738-44. PMC: 2864379. DOI: 10.3324/haematol.2009.016345. View

13.

David M, Cross N, Burgstaller S, Chase A, Curtis C, Dang R . Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders. Blood. 2006; 109(1):61-4. DOI: 10.1182/blood-2006-05-024828. View

14.

Cools J, DeAngelo D, Gotlib J, Stover E, Legare R, Cortes J . A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003; 348(13):1201-14. DOI: 10.1056/NEJMoa025217. View

15.

Still I, Chernova O, Hurd D, Stone R, Cowell J . Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11. Blood. 1997; 90(8):3136-41. View

16.

Rymes N, White P, Pomfret M, Smith H, Starczynski J, Johnson R . A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. A case report. Acta Haematol. 2002; 107(2):98-100. DOI: 10.1159/000046638. View

17.

Chen J, DeAngelo D, Kutok J, Williams I, Lee B, Wadleigh M . PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci U S A. 2004; 101(40):14479-84. PMC: 521956. DOI: 10.1073/pnas.0404438101. View

18.

Lierman E, Lahortiga I, Van Miegroet H, Mentens N, Marynen P, Cools J . The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors. Haematologica. 2007; 92(1):27-34. DOI: 10.3324/haematol.10692. View

19.

Jovanovic J, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G . Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood. 2007; 109(11):4635-40. DOI: 10.1182/blood-2006-10-050054. View

20.

Lourenco G, Ortega M, Freitas L, Bognone R, Fattori A, Lorand-Metze I . The rare t(6;8) (q27;p11) translocation in a case of chronic myeloid neoplasm mimicking polycythemia vera. Leuk Lymphoma. 2008; 49(9):1832-5. DOI: 10.1080/10428190802163347. View